Poland· PL-100014223
Cholinex
A choline salicylate product containing cholini salicylas, registered in Poland by STADA Arzneimittel AG. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Choline salicylate is registered in 4 of 19 countries.
Countries holding a registration under ATC N02BA03 (choline salicylate), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Choline salicylate · ATC N02BA03
4 / 19 countries
- Belgiumprice
- Ireland
- Polandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Cholini salicylas
- Manufacturer
- STADA Arzneimittel AG
- Country
- Poland (PL)
- ATC code
- N02BA03
- ATC class
- Choline salicylate
- Defined daily dose
- 3 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909990170111
- gtin05909990170128
- gtin05909990712694
- gtin05909990712700
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
133 interactions on record for choline salicylate.
Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Choline salicylate · interactions on record
133 records
- 10 severe
- 116 moderate
- 7 minor
Most severe, free to view
- MethotrexateL01BA01severe
- RamucirumabL01FG02severe
- RamucirumabL01XC21severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Choline salicylate in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a38fb9a4-2921-4d10-962c-119bece8ed63 GET /v1/drugs/a38fb9a4-2921-4d10-962c-119bece8ed63?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pastylki twarde",
"source": "urpl",
"strength": "150 mg",
"packaging": "05909990170111 ¦ OTC ¦ 2478\n16 pastylek\n05909990170128 ¦ OTC ¦ 14816\n8 pastylek\n05909990712694 ¦ OTC ¦ 51506\n24 pastylek\n05909990712700 ¦ OTC ¦ 51507\n32 pastylek",
"substance": "Cholini salicylas 150 mg",
"common_name": "Cholini salicylas",
"pl_product_id": "100014223",
"pozwolenie_nr": "01701",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about choline salicylate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.